Berotralstat
Medication
- 1 min read
- 3 chapters
Related on Lably
Through Medication
The most common side effects include abdominal pain, vomiting, diarrhea, back pain, and heartburn.
Berotralstat was approved for medical use in the United States in December 2020, and in the European Union in April 2021.
Medical uses
Berotralstat is indicated for prophylaxis to prevent attacks of hereditary angioedema.
Sign in to keep reading
2 more chapters are free with a Lably account.
History
Berotralstat was approved based on evidence from one clinical trial (Trial 1 / NCT03485911) of 120 participants with hereditary angioedema. The trial was conducted at 40 sites in the United States, the European Union, and Canada. Trial investigators evaluated participants twelve years of age and older with hereditary angioedema for eight weeks to determine the number of attacks for each participant. The trial enrolled only participants who had at least two attacks during the eight-week period. Participants were assigned to receive one of two doses of berotralstat or placebo once every day for 24 weeks. Neither the participants nor the investigators knew which treatment was being given until after the trial was completed. All participants could use other medications for treatment of attacks.
Society and culture
Legal status
Berotralstat was approved for medical use in the United States in December 2020, and in the European Union in April 2021.
Names
Berotralstat is the international nonproprietary name.